Catheter Extension Trial for Early Vesicovaginal Fistula Repair Failures
NCT ID: NCT03029130
Last Updated: 2017-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
232 participants
INTERVENTIONAL
2017-01-01
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stromal Vascular Fraction (SVF) for Treatment of Recto-vaginal Fistula
NCT01548092
A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas
NCT05641844
Transvaginal Versus Transperineal Repair of Rectocele
NCT03801291
Feasibility and Safety of Additional Injection of Autologous Platelet-rich Stroma to Surgical Treatment of Rectovaginal Fistulas
NCT06798935
Semiflex Assisted Vacuum Therapy for Perianal Abscesses/Sinuses and Fistula: a Pilot Study
NCT06446635
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Catheter Extension
Patients in this arm will have a foley catheter re-passed, to remain in situ for an additional 14 days, after which time the catheter will be removed and the patient discharged to return for follow up exam at 3 months postop.
Catheter extension
Foley transurethral catheter placed to allow continuous drainage of urine.
Discharge
Patients in this arm will be discharged, to return for follow up exam at 3 months postop.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Catheter extension
Foley transurethral catheter placed to allow continuous drainage of urine.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* concomitant bladder stone(s),
* one or more ureters outside of the bladder,
* urethrovaginal fistula,
* multiple fistulas (more than one),
* dye leak / fistulous leak present at end of surgical procedure,
* radiation-induced fistula,
* fistula caused by cancer or infection (such as lymphogranuloma venereum),
* continence procedures being performed (such as pubovaginal sling),
* rectovaginal fistula,
* pregnancy,
* fistula breakdown of greater than 2cm identified on postoperative dye test.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Evangel VVF Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steven Shephard
Fistula Surgeon
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EvangelWFC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.